Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy

Nen Chung Chang, Zhi Yang Lai, Tze Che Wang

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The aim of the study was to determine whether enalapril monotherapy can improve left ventricular diastolic dysfunction (LVDD) in young and mild hypertensive patients without concomitant left ventricular hypertrophy (LVH). Fifty patients with hypertension ≤160/100 mm Hg, aged ≤50 years, normal two-dimensional echocardiographic (2-D echo) measurements, and LVDD were enrolled in this study. The LVDD was defined as a transmitral early (E) to atrial (A) peak velocity ratio of ≤1. The mean documented hypertension was 6.3 years. The mean daily dose of enalapril was 13 mg. Baseline and 24-month follow-up echocardiograms were evaluated. Thirty-eight age- and sex-matched healthy subjects served to establish the normal reference values of 2-D echo measurements. After treatment, peak early diastolic velocity (E) (49 ± 6 cm/sec v 48 ± 10 cm/sec; P = not significant), peak atrial velocity (A) (62 ± 9 cm/sec v 62 ± 10 cm/sec; P = not significant), and E/A ratio (0.80 ± 0.10 v 0.78 ± 0.13; P = not significant) remained unchanged. Moreover, early to atrial velocity-time integral ratio (1.24 ± 0.08 v 1.23 ± 0.11; P = not significant) did not change. The left ventricular mass index, relative wall thickness, left ventricular end-systolic diameter, left atrial diameter, fractional shortening, heart rate, and body mass index did not show significant changes in all hypertensive patients. In conclusion, long-term antihypertensive therapy with enalapril did not lead to an improvement of LVDD in young and mild hypertension patients without concomitant LVH.

Original languageEnglish
Pages (from-to)909-914
Number of pages6
JournalAmerican Journal of Hypertension
Volume9
Issue number9
DOIs
Publication statusPublished - Sep 1996

Fingerprint

Enalapril
Left Ventricular Dysfunction
Hypertrophy
Left Ventricular Hypertrophy
Hypertension
Reference Values
Antihypertensive Agents
Healthy Volunteers
Body Mass Index
Heart Rate
Therapeutics

Keywords

  • Echocardiography
  • Enalapril
  • Hypertension
  • Left ventricular diastolic dysfunction
  • Left ventricular hypertrophy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy. / Chang, Nen Chung; Lai, Zhi Yang; Wang, Tze Che.

In: American Journal of Hypertension, Vol. 9, No. 9, 09.1996, p. 909-914.

Research output: Contribution to journalArticle

@article{783902f3ae484240b3916bab5b77d3a4,
title = "Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy",
abstract = "The aim of the study was to determine whether enalapril monotherapy can improve left ventricular diastolic dysfunction (LVDD) in young and mild hypertensive patients without concomitant left ventricular hypertrophy (LVH). Fifty patients with hypertension ≤160/100 mm Hg, aged ≤50 years, normal two-dimensional echocardiographic (2-D echo) measurements, and LVDD were enrolled in this study. The LVDD was defined as a transmitral early (E) to atrial (A) peak velocity ratio of ≤1. The mean documented hypertension was 6.3 years. The mean daily dose of enalapril was 13 mg. Baseline and 24-month follow-up echocardiograms were evaluated. Thirty-eight age- and sex-matched healthy subjects served to establish the normal reference values of 2-D echo measurements. After treatment, peak early diastolic velocity (E) (49 ± 6 cm/sec v 48 ± 10 cm/sec; P = not significant), peak atrial velocity (A) (62 ± 9 cm/sec v 62 ± 10 cm/sec; P = not significant), and E/A ratio (0.80 ± 0.10 v 0.78 ± 0.13; P = not significant) remained unchanged. Moreover, early to atrial velocity-time integral ratio (1.24 ± 0.08 v 1.23 ± 0.11; P = not significant) did not change. The left ventricular mass index, relative wall thickness, left ventricular end-systolic diameter, left atrial diameter, fractional shortening, heart rate, and body mass index did not show significant changes in all hypertensive patients. In conclusion, long-term antihypertensive therapy with enalapril did not lead to an improvement of LVDD in young and mild hypertension patients without concomitant LVH.",
keywords = "Echocardiography, Enalapril, Hypertension, Left ventricular diastolic dysfunction, Left ventricular hypertrophy",
author = "Chang, {Nen Chung} and Lai, {Zhi Yang} and Wang, {Tze Che}",
year = "1996",
month = "9",
doi = "10.1016/S0895-7061(96)00114-8",
language = "English",
volume = "9",
pages = "909--914",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy

AU - Chang, Nen Chung

AU - Lai, Zhi Yang

AU - Wang, Tze Che

PY - 1996/9

Y1 - 1996/9

N2 - The aim of the study was to determine whether enalapril monotherapy can improve left ventricular diastolic dysfunction (LVDD) in young and mild hypertensive patients without concomitant left ventricular hypertrophy (LVH). Fifty patients with hypertension ≤160/100 mm Hg, aged ≤50 years, normal two-dimensional echocardiographic (2-D echo) measurements, and LVDD were enrolled in this study. The LVDD was defined as a transmitral early (E) to atrial (A) peak velocity ratio of ≤1. The mean documented hypertension was 6.3 years. The mean daily dose of enalapril was 13 mg. Baseline and 24-month follow-up echocardiograms were evaluated. Thirty-eight age- and sex-matched healthy subjects served to establish the normal reference values of 2-D echo measurements. After treatment, peak early diastolic velocity (E) (49 ± 6 cm/sec v 48 ± 10 cm/sec; P = not significant), peak atrial velocity (A) (62 ± 9 cm/sec v 62 ± 10 cm/sec; P = not significant), and E/A ratio (0.80 ± 0.10 v 0.78 ± 0.13; P = not significant) remained unchanged. Moreover, early to atrial velocity-time integral ratio (1.24 ± 0.08 v 1.23 ± 0.11; P = not significant) did not change. The left ventricular mass index, relative wall thickness, left ventricular end-systolic diameter, left atrial diameter, fractional shortening, heart rate, and body mass index did not show significant changes in all hypertensive patients. In conclusion, long-term antihypertensive therapy with enalapril did not lead to an improvement of LVDD in young and mild hypertension patients without concomitant LVH.

AB - The aim of the study was to determine whether enalapril monotherapy can improve left ventricular diastolic dysfunction (LVDD) in young and mild hypertensive patients without concomitant left ventricular hypertrophy (LVH). Fifty patients with hypertension ≤160/100 mm Hg, aged ≤50 years, normal two-dimensional echocardiographic (2-D echo) measurements, and LVDD were enrolled in this study. The LVDD was defined as a transmitral early (E) to atrial (A) peak velocity ratio of ≤1. The mean documented hypertension was 6.3 years. The mean daily dose of enalapril was 13 mg. Baseline and 24-month follow-up echocardiograms were evaluated. Thirty-eight age- and sex-matched healthy subjects served to establish the normal reference values of 2-D echo measurements. After treatment, peak early diastolic velocity (E) (49 ± 6 cm/sec v 48 ± 10 cm/sec; P = not significant), peak atrial velocity (A) (62 ± 9 cm/sec v 62 ± 10 cm/sec; P = not significant), and E/A ratio (0.80 ± 0.10 v 0.78 ± 0.13; P = not significant) remained unchanged. Moreover, early to atrial velocity-time integral ratio (1.24 ± 0.08 v 1.23 ± 0.11; P = not significant) did not change. The left ventricular mass index, relative wall thickness, left ventricular end-systolic diameter, left atrial diameter, fractional shortening, heart rate, and body mass index did not show significant changes in all hypertensive patients. In conclusion, long-term antihypertensive therapy with enalapril did not lead to an improvement of LVDD in young and mild hypertension patients without concomitant LVH.

KW - Echocardiography

KW - Enalapril

KW - Hypertension

KW - Left ventricular diastolic dysfunction

KW - Left ventricular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=0030250301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030250301&partnerID=8YFLogxK

U2 - 10.1016/S0895-7061(96)00114-8

DO - 10.1016/S0895-7061(96)00114-8

M3 - Article

C2 - 8879348

AN - SCOPUS:0030250301

VL - 9

SP - 909

EP - 914

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 9

ER -